Validity of Cancer Antigen-125 (CA-125) and Risk of Malignancy Index (RMI) in the Diagnosis of Ovarian Cancer

OBJECTIVE: We sought to determine the validity of cancer antigen 125 (CA-125) and the risk of malignancy index (RMI) in the diagnosis of ovarian cancer in women presenting with adnexal lesions of various histopathology types. METHODS: This retrospective cross- sectional study included all women with...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oman Med J
Hlavní autoři: Al-Musalhi, Khawla, Al-Kindi, Manal, Ramadhan, Fatma, Al-Rawahi, Thuraya, Al-Hatali, Khalsa, Mula-Abed, Waad-Allah
Médium: Artigo
Jazyk:Inglês
Vydáno: OMJ 2015
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4678449/
https://ncbi.nlm.nih.gov/pubmed/26675326
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5001/omj.2015.85
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky